Hrt Financial LP Ab Cellera Biologics Inc. Transaction History

Hrt Financial LP

$18.1 Billion
Q3 2024

A detailed history of Hrt Financial LP transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Hrt Financial LP holds 129,904 shares of ABCL stock, worth $379,319. This represents 0.0% of its overall portfolio holdings.

Number of Shares

129,904

Holding current value

$379,319

% of portfolio

0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$2.39 - $3.49 $310,470 - $453,364	129,904 New	129,904 $336,000
Q4 2023 Feb 09, 2024	BUY	$3.91 - $5.93 $110,891 - $168,180	28,361 Added 45.6%	90,562 $517,000
Q3 2023 Nov 13, 2023	SELL	$4.6 - $7.95 $308,250 - $532,737	-67,011 Reduced 51.86%	62,201 $286,000
Q2 2023 Aug 11, 2023	SELL	$5.66 - $7.59 $2.42 Million - $3.24 Million	-427,062 Reduced 76.77%	129,212 $834,000
Q1 2023 May 12, 2023	BUY	$7.31 - $11.18 $4.07 Million - $6.22 Million	556,274 New	556,274 $4.19 Million
Q2 2022 Aug 12, 2022	SELL	$5.72 - $10.65 $357,888 - $666,349	-62,568 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$7.46 - $14.14 $466,757 - $884,711	62,568 New	62,568 $610,000
Q2 2021 Aug 16, 2021	SELL	$20.19 - $34.17 $552,519 - $935,096	-27,366 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$23.29 - $53.2 $637,354 - $1.46 Million	27,366 New	27,366 $929,000

Others Institutions Holding ABCL

# of Institutions

154

Shares Held

109M

Call Options Held

153K

Put Options Held

194K

Baker Bros. Advisors LP New York, NY

27.5M
Shares

$80.4 Million
0.76% of portfolio
Baillie Gifford & CO

12.9M
Shares

$37.7 Million
0.03% of portfolio
Voya Investment Management LLC Atlanta, GA

10.6M
Shares

$31 Million
0.03% of portfolio
Prosight Management, LP Dallas, TX

9.08M
Shares

$26.5 Million
6.31% of portfolio
Ubs Asset Management Americas Inc Chicago, IL

4.59M
Shares

$13.4 Million
0.0% of portfolio

View Full List

About AbCellera Biologics Inc.

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $833M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

More about ABCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account